CH516566A - Verfahren zur Herstellung von 2,4-Dihydroxy-5-aminomethyl-6-methylpyrimidinen - Google Patents

Verfahren zur Herstellung von 2,4-Dihydroxy-5-aminomethyl-6-methylpyrimidinen

Info

Publication number
CH516566A
CH516566A CH1544068A CH1544068A CH516566A CH 516566 A CH516566 A CH 516566A CH 1544068 A CH1544068 A CH 1544068A CH 1544068 A CH1544068 A CH 1544068A CH 516566 A CH516566 A CH 516566A
Authority
CH
Switzerland
Prior art keywords
methylpyrimidines
aminomethyl
dihydroxy
preparation
Prior art date
Application number
CH1544068A
Other languages
English (en)
Inventor
Murakami Masuo
Kawashima Yuji
Ito Noriki
Yano Kuniichiro
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of CH516566A publication Critical patent/CH516566A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1544068A 1967-10-18 1968-10-16 Verfahren zur Herstellung von 2,4-Dihydroxy-5-aminomethyl-6-methylpyrimidinen CH516566A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6652067 1967-10-18
JP3980368 1968-06-10

Publications (1)

Publication Number Publication Date
CH516566A true CH516566A (de) 1971-12-15

Family

ID=26379203

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1544068A CH516566A (de) 1967-10-18 1968-10-16 Verfahren zur Herstellung von 2,4-Dihydroxy-5-aminomethyl-6-methylpyrimidinen

Country Status (5)

Country Link
US (1) US3651063A (de)
CH (1) CH516566A (de)
DE (1) DE1802922A1 (de)
FR (1) FR7739M (de)
GB (1) GB1241339A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070287716A1 (en) * 2004-10-28 2007-12-13 Hu Essa H Pyrimidine and Quinoline Potentiators of Metabotropic Glutamate Receptors

Also Published As

Publication number Publication date
FR7739M (de) 1970-03-09
US3651063A (en) 1972-03-21
GB1241339A (en) 1971-08-04
DE1802922A1 (de) 1969-05-14

Similar Documents

Publication Publication Date Title
CH505118A (de) Verfahren zur Herstellung von 1,2,4-Triazin-5-onen
CH481110A (de) Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
CH518953A (de) Verfahren zur Herstellung von 2-Methyl-3-carbonsäure-amidochinoxalin-di-N-oxiden-(1,4)
CH503674A (de) Verfahren zur Herstellung von 4-Halogen-2-tert.butoxybutanen
CH526524A (de) Verfahren zur Herstellung von 6a,6B-Difluorsteroiden
CH512499A (de) Verfahren zur Herstellung von 2-Halogenmethyl-3-carbonsäureamido-chinoxalin-di-N-oxiden-(1,4)
CH507930A (de) Verfahren zur Herstellung von 5-Methyl-4-hydroxy-2,3-dihydrofuran-3-on
CH527828A (de) Verfahren zur Herstellung von 2,4-Benzdiazepinen
CH506537A (de) Verfahren zur Herstellung von 2-Isothiuroniummethyl-3-carbonsäureamido-chinoxalin-di-N-oxid(1,4)-halogeniden
CH508640A (de) Verfahren zur Herstellung von 2,4-Bis-alkylamino-6-chlor-s-triazinen
CH504448A (de) Verfahren zur Herstellung von 3-Amino-s-triazolo-(4,3-a)-pyrazinen
CH524563A (de) Verfahren zur Herstellung von 3,5-Diniederalkoxy-homophthalsäuren
CH493552A (de) Verfahren zur Herstellung von 3-Oxo-5-chlor-1,2,4-thiadiazolinium-Salzen
CH479544A (de) Verfahren zur Herstellung von 2,5-Diamino-3,6-dihalogen-p-benzochinonen
AT284353B (de) Verfahren zur Herstellung von 3,5-Dioxo-4,5-seco-13β-R-gona-9,11-dienen
AT281022B (de) Verfahren zur Herstellung von 1-n-Butyl-2',6'-pipecoloxylidid
AT298686B (de) Verfahren zur Herstellung von 6,7-Benzomorphan-Derivaten
CH504454A (de) Verfahren zur Herstellung von 3-Imino-1,2-benzisothiazolinen
CH533093A (de) Verfahren zur Herstellung von 17B-Hydroxy-15B,16B-methylen-4-androsten-3-on
CH506526A (de) Verfahren zur Herstellung von 4-Phenylimino-1,4-Dihydrochinolinen
CH484932A (de) Verfahren zur Herstellung von 1,2-Benzisothiazolen
CH487822A (de) Verfahren zur Herstellung von 1,4-Dihalogenanthrachinonen
CH516566A (de) Verfahren zur Herstellung von 2,4-Dihydroxy-5-aminomethyl-6-methylpyrimidinen
CH507210A (de) Verfahren zur Herstellung von 2,3-Dihalogenacrylaniliden
CH513185A (de) Verfahren zur Herstellung von 3-Carbonsäureamidochinoxalin-di-N-oxiden-(1.4)

Legal Events

Date Code Title Description
PL Patent ceased